Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo.
Cufí S, Bonavia R, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, Martin-Castillo B, Barrajón-Catalán E, Visa J, Segura-Carretero A, Joven J, Bosch-Barrera J, Micol V, Menendez JA.
Cufí S, et al. Among authors: oliveras ferraros c.
Sci Rep. 2013;3:2459. doi: 10.1038/srep02459.
Sci Rep. 2013.
PMID: 23963283
Free PMC article.